Dongwha's DW166HC likely to be No. 2 new drugs in Korea.

SK pharmaceutical obtained the manufacturing licence of a platinum complex preparation as a new drug with passing through the clinical phase II studies only, which was exceptional for an anticancer drug while provisionally requiring phase III studies for an authorization of new drugs.

Article 6 Paragraph 1 No. 6 e of the drug safety and efficacy examination regulation stipulates that a comme...